SpaceX began trading under the ticker SPCX on June 12 at $161 per share, well above its $135 IPO price, and has since climbed to $178.42 -- delivering a 32% return to anyone who secured an IPO allocation. The greenshoe option was exercised on June 15, meaning the underwriting syndicate purchased an additional allotment of shares to stabilize the price, a clear signal that institutional demand significantly exceeded supply even at post-IPO levels. Total capital raised stands at $85.7 billion, making it the largest IPO in history by a factor of three.
The market mechanics tell a story beyond the ticker. SpaceX priced conservatively at $135 despite demand that could have supported $150+, a deliberate strategy to ensure a strong first-day pop that would generate positive headlines and momentum. Goldman Sachs, Morgan Stanley, and JPMorgan led the syndicate, and the allocation process reportedly prioritized long-only institutional investors over hedge funds -- a signal that SpaceX (and Musk) wanted a stable shareholder base rather than maximum proceeds. The dual-class share structure ensures Musk retains 82%+ voting control regardless of how shares trade.
“This isn't just an IPO -- it's the reopening of the late-stage liquidity market that's been frozen since 2022”
For the broader IPO market, SpaceX is the dam breaking. The late-stage liquidity market has been effectively frozen since 2022, with LPs across hundreds of VC funds waiting for distributions that never came. SpaceX just proved that mega-cap tech IPOs can price above private marks, trade up on day one, and generate the kind of returns that justify the illiquidity premium VCs charge. Every GP sitting on a $5B+ portfolio company just got a new slide for their LP meeting.
The pipeline is moving fast now. Klarna is expected to price within weeks. Stripe's confidential S-1 is reportedly near finalization. Anthropic and OpenAI are both in the queue. If SpaceX sustains its trading levels through Q3, 2026 could surpass 2021 as the largest IPO year in history -- with the critical difference that these companies have real revenue and, in many cases, actual profits.